Delivery Order SPE2DB20D7061-SPE2DB26FSLD7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Jardiance 25 mg tablets (90-count) valued at $5,638.65. This competitively awarded, firm fixed-price delivery order is set to be completed by August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $1,864.56. This firm fixed-price delivery order, with an ultimate completion date of October 27, 2025, represents a continuation of AmerisourceBergen's pharmaceutical supply support under its existing contract vehicle with DLA. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a ceiling value of $30,082.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $11,531.50. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $60,027.48. This non-set-aside delivery order is scheduled for ultimate completion by August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $10,280.04. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by November 3, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 25 mg tablets in a quantity of 90 units, with a ceiling value of $8,606.87. This competitively awarded delivery order utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a contract ceiling value of $32,802.10. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $51,243.85. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Jardiance 25 mg tablets (90-count packaging) valued at $6,733.04 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by October 24, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order against AmerisourceBergen's larger Indefinite...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB26FSLD7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $97,854.10. This firm fixed-price delivery order, with an ultimate completion date of November 7, 2025, represents a pharmaceutical supply requirement for federal medical procurement. The award was made on a competitive basis without set-aside designation, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military and federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to serve as a critical vendor for federal medical procurement needs through its extensive portfolio of pharmaceutical products and medical supplies. The company's federal contract performance demonstrates substantial capability in fulfilling diverse therapeutic requirements across military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, and medical supplies. Through its DLA Troop Support Medical contract, AmerisourceBergen supports customers including the Defense Health Agency and U.S. Coast Guard, positioning the company as a key provider within the federal pharmaceutical supply chain as the Defense Logistics Agency implements its Pharmaceutical Prime Vendor Global Program Generation V strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $97.9k | 11/6/25 |